COMMUNIQUÉS West-GlobeNewswire

-
Bilan semestriel du contrat de liquidité avec Invest Securities
16/07/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2025
16/07/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2025
16/07/2025 -
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
16/07/2025 -
eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization
16/07/2025 -
Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation
16/07/2025 -
Virbac: au premier semestre 2025, le chiffre d'affaires a enregistré une solide croissance de +5,6% à taux de change et périmètre constants
16/07/2025 -
Aesthetic Business Strategist Dr. Kalpana Sundar to Host Transformational Profit Accelerator Bootcamp for Medspa Owners in Albuquerque – August 7–10, 2025
16/07/2025 -
Dallas Business Journal Recognizes U.S. Oral Surgery Management for Continued Growth
16/07/2025 -
Where to Buy Kratom Online in 2025: Happy Go Leafy Ranked Among the Best Kratom Brands for Quality and Transparency
16/07/2025 -
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
16/07/2025 -
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
16/07/2025 -
Intuitive demonstrates telesurgery capabilities
16/07/2025 -
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering
16/07/2025 -
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member
16/07/2025 -
Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations
16/07/2025 -
Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos
16/07/2025 -
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
16/07/2025 -
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
16/07/2025
Pages